Abstract
EFFECT OF VASA DHOOMAPANA (VASA NEBULIZATION) ON SERUM ALPHA-1 ANTI TRYPSIN WITH SPECIAL REFERENCE TO EARLY COPD - A CLINICAL TRIAL

*Dr. R. Jayaraj

ABSTRACT

Introduction: Chronic obstructive pulmonary disease (COPD) is a diseased state characterized by progressive development of chronic air flow limitation that is not fully reversible. Incidence of Alpha-1 antitrypsin deficiency in patients persisting with COPD is associated with tobacco smoking and it is the single most important and the most prevalent risk factor for the development of COPD. Dhoomapana (herbal nebulization) has been advocated as an important treatment modality in Ayurveda. Aim: Present study was undertaken to evaluate the effect of Vasa Dhoomapana on serum Alpha-1 antitrypsin with special reference to early COPD. Materials and methods: 10 patients who were suspected to have COPD (Tamaka Swasa) were selected and estimation of serum Alpha -1 antitrypsin was done before and after 15 days of Vasa nebulization. Validation was done using BOLD COPD questionnaire and visual analogue scale. Results: Out of ten, seven cases showed improvement in the level of serum Alpha -1 antitrypsin. While all the ten cases showed improvement in terms of lung performance as measured by respirometer. Conclusion: Vasa nebulization is a simple, cost effective and safe procedure which can be used to improve the serum concentration of Alpha 1 antitrypsin, thereby reducing COPD symptoms. It also improves the lung performance effectively.

Keywords: Vasa, Nebulization, Dhoomapana, BOLD questionnaire.


[Full Text Article]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tangudu Nagabhusana Rao

Download Article : Click here

News & Updation

  • NEW JUNE ISSUE PUBLISHED

    JUNE 2020 Issue has been successfully launched on 1 June 2020.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT